Hit the road Jack! W. FRANK PEACOCK, MD, FACEP, FACC

Size: px
Start display at page:

Download "Hit the road Jack! W. FRANK PEACOCK, MD, FACEP, FACC"

Transcription

1 Hit the road Jack! W. FRANK PEACOCK, MD, FACEP, FACC

2 Visits 130,000,000 annually 10.4 M chest pain (8.0%) 4.1 M sent home non-cardiac 6.24 M suspected or actual cardiac 50,000 MIs 3.1 M non-cardiac (50%) 1.2 M AMI (20%) 1.5 M UA (24%) 374,400 sudden death (6%)

3 Musculoskeletal Pain Blunt Chest Trauma Mediastinitis IVDA Pulm Infarction Anxiety Pulmonary Embolus Panic Attack Breast Abcess Aortic Dissection Pneumothorax Empyema Pneumonia Breast Implant Tietze s disease Mondor s Syndrome Thoracic Spine Ds GERD Asthma Herpes Zoster Contact Dermatitis Breast Cancer Mallory- Weiss Subdiaphrag Abcess Sickle cell Anemia Lung Cancer Amniotic Fluid Embolus Myocardial Pain Boerhave s

4 Hs Tn (STATISTICAL) Definition You can t have it both ways Sensitivity Specificity TP/(TP+FN) TN/(TN+FP)

5 How often is the EKG diagnostic? 2% 10.4 million annual ER CP STEMI = 208, ER s = 59 STEMI/ER/yr No ECG = 10,192,000/yr = 2,912/ER/yr = to find 59 N=10,869 Pope JH, et al. Missed Diagnosis of Acute Cardiac Ischemia in the ED, NEJM 2000;342:

6 How good are the parts? Than M. Lancet, DOI: /S (11) Sensitivity NPV ECG POC markers TIMI POC + ECG TIMI + ECG ADP

7 How often is the Tn diagnostic? 8% 10.4 million annual ER CP Total NSTEMI = 822, USA ER s = 238/ER/yr 9,568,000 Tn/yr Tn/ER to find 238 N=10,869 Pope JH, et al. Missed Diagnosis of Acute Cardiac Ischemia in the ED NEJM 2000;342:

8 What is the fastest troponin? POC vs the central lab. 5 hospitals 4609 Tn POC samples 3447 split and sent to lab for CKMB Locale Hosp Type Transp POC Tn ED Univ Pneumo tube ED Univ Courier 22±0.5 (n=855) 21±0.2 (n=1879) CCU Rural Nurses 12±0.5 (n=471) ED Muni Pneumo 22±0.8 (n=706) tube ED Univ Pneumo 18±0.5 tube (n=698) All 20±0.2 (n=4609) CL CKMB 107±2.3 (n=1744) 72±1.7 (n=689) 147±64.1 (n=150) 90±0.5 (n=185) 52±1.4 (n=679) 85±1.5 (n=3447) Diff (mins) 86±2.3 50± ± ±1.1 34±1.4 65±1.5 Gaze D et al. Point of Care: The Journal of Near-Patient Testing & Technology. 2004;3:

9 How good are the parts? Than M. Lancet, DOI: /S (11) Sensitivity NPV ECG POC markers TIMI POC + ECG TIMI + ECG ADP

10 How sensitive does it have to be? 100,000 Annual ER visits 8% CP = 8k/yr = 22/day Sn = 95% Miss 5 out of 100 Miss 1 AMI every 4.5 days Miss 81 AMI/yr Sn=99.5% Miss 1 out of 200 Miss 1 every 9 days

11 OK it has to go to the lab, but how about one and done???

12 Why isn t 1 troponin enough? ADAPT and APACE had presentations at ~4 hours. Your cutpoint is? Lets say 13 pg/ml Mrs Jones normally lives at 4 She presents 45 minutes after CP onset Tn is 12 (300% increase from baseline)

13 Meta analysis of 23 papers Elecsys hs TnT at ED presentation LOD=5 ng/l, LOQ=13 ng/l (the lowest TnT that has CV of 10%) 99th %ile of healthy pop =14 ng/l Results N=9428 Pre-test probability of AMI 21% Most patients presented within 12 hrs of symptom onset study medians hrs One and done? Using 14 ng/l cutpoint Sn= 89.5% (95% CI 86.3% to 92.1%), Sp=77.1% (68.7% to 83.7%). Cutpoints determine miss rate For 100 consecutive patients 5 ng/l will miss 2-3 AMI 3 ng/l will miss 0 AMI BMJ

14 718 consecutive ED suspect AMI MI/USA 238 (33.1%) Reichlin T. N Engl J Med 2009;361:

15 Chest Pain Protocol VS. ADP A CHEST PAIN PROTOCOL A series of activities to identify a patient as: 1) Having an event 2) Being at risk for having an event AN ACCELERATED DIAGNOSTIC PROTOCOL A series of activities to identify the patient as: 1) NOT having an event 2) Being at low risk for having an event

16 Why an ADP? Accelerated Diagnostic Protocol Reason for an ADP ER docs vs risk scores Docs are risk adverse Docs always admit more than scores

17 Why do we admit sooo many? ER Dr. LAWYER

18 ADP is for discharging! Maybe that is a good idea? Risk Scores ADP 1) Non-Dx ECG 2) (-) Tn x2 3) Low Risk Score TIMI HEART EDACS CRUSADE GRACE

19 TIMI Risk Score: 2 week MACE Risk factors: Age 65 years 3 risk factors for CAD Prior coronary stenosis 50% ST-segment deviation on ECG 2 anginal events in last 24 hours Use of ASA in last 7 days Elevated serum cardiac markers CK-MB or troponin Rate of Composite Endpoint (Days 1-14), % / /7 Number of Risk Factors 1 Each risk factor is = 1 point, and total represents TIMI Risk Score Event rates (all-cause mortality, MI, or UTVR) increase with each 1-point increase in score Antman EM et al. JAMA. 2000;284:

20 How good are the parts? Than M. Lancet, DOI: /S (11) Sensitivity NPV ECG POC markers TIMI POC + ECG TIMI + ECG ADP

21 HEART Score for 6 week MACE MACE = AMI, PCI, CABG, (+) cath, death Hx: Hi =2, Mod =1, Slight =0 ECG: Sig ST dep =2, NS repol =1, Nl =0 Age: 65 =2, =1, 45 =0 Risks: 3 =2, 1-2 =1, 0=0 RISKS Hyperchole, HTN, DM Tobbacco (+) FH, Obesity Tn: 3x ULN =2 1-3 ULN =1 ULN =0 Low risk = 0-3; <2% MACE risk

22 HEART Pathway Randomized Trial 282 ED suspected ACS patients, randomized to HEART or standard tx HEART N=141, with score < 4, negative Tn at 0 and 3 hours 75 low risk, 56 discharged Standard care N=141, per ACC/AHA guidelines X low risk, 26 discharged. Results: No MACE in either arm HEART lower objective cardiac testing; 68.8 vs 56.7% (P=0.048) lower LOS; 9.9 vs 21.9 hours (P=0.013) higher early discharges by 21.3% (39.7% versus 18.4%; P<0.001). Mahler S. Circ Cardiovasc Qual Outcomes March ; 8(2):

23 EDACS-ADP Emergency Department Assessment Chest Pain Score - Accelerated Diagnostic Procedure Characteristic Parameter Points History yo with CAD, or >2 risk factors +4 Age > Characteristic Parameter Points Sex Male +6 Signs and Symptoms Diaphoresis +3 Arm or shoulder radiation Pain occurred or worsened with inspiration Pain is reproduced with palpation Low Risk Criteria EDACS Score <16 No new ECG ischemia Negative 0 and 2h Tn

24 PEARL Comparing Scores EDACS HEART-2 PEARL data set: 7 Eds N=458 Patient with suspected ACS HEART -1 TIMI GRACE Dr documented risk of MI before Tn results as Low, Moderate, or High Singer A. Am JEM, 2017, Jan 5. pii: S (17) doi: /j.ajem [Epub ahead of print]

25 Scores: standard cutpoint Low risk definition N % with AMI Sensitivity Clinical Low ( ) 88.7 ( ) HEART ( ) 91.5 ( ) TIMI (0-12.9) 100 ( ) GRACE < ( ) 98.6 ( ) EDACS < ( ) 97.1 ( ) Singer A. Am J EM Jan 5. pii: S (17) doi: /j.ajem

26 Performance: Sensitivity set at 99% Sensitivity set at 99% Cutoff % Low Risk Clinical HEART HEART TIMI 0 7 GRACE EDACS Singer A. Am J EM Jan 5. pii: S (17) doi: /j.ajem

27 How many will the ADP D/C? 10.4 million annual ER CP 3500 USA ER s ED D/C rate # of patients 7.0 (TIMI) 728, (HEART) 1,965, (EDACS) 3,567,200 77% (TRAPID) 8,008,000

28 High Sensitivity Troponin in the USA FDA clears blood test to help diagnose patients with a suspected MI Jan 19, 2017 The FDA granted a 510(k) clearance for the Elecsys Troponin T Gen 5 STAT blood test for patients with a suspected MI.

29 Increased Troponin Sensitivity = More ED Discharges Patients Discharged Early (%) ASPECT 1 ctni 50 ng/l 20.0 ADAPT 2 ctni 30 ng/l 38.6 APACE 3 ctni 26.2 ng/l 63.4 TRAPID-AMI 4 ctnt 12 ng/l; Δ1 hour 3 ng/l 1) Than M, Cullen L, Reid C, et al. Lancet. 2011;377: ) Than M, Cullen L, Aldous S, et al. J Am Coll Cardiol. 2012;59(23): ) Cullen L, Mueller C, Parsonage WA, et al. J am Coll Cardiol. 2013;62(14): ) Mueller C, Giannitsis E, Christ M, et al. Ann Emerg Med. 2016;68(1):76-87.

30 2015 ESC Guidelines The NPV for MI in patients assigned rule-out exceeded 98% in several large validation cohorts Eur Heart J Jan 14;37(3):

31 Will the ESC guidelines work in the US? hsctnt and I at 0 and 3 h postpresentation Purpose: validate the ESC Working Group on Acute Cardiac Care rule-in algorithm 1061 hstni 985 hstnt Sn of 99th %ile to R/O AMI HsTnI 93.2% HsTnT 94.8% Pickering JW, et al. Heart 2016;0:1 9.

32 How quickly can I make a decision? ECG 10 Tn (central lab) 90 Risk Score (EDACS) Some admitted Repeat 3 hrs Returns for decision. ~4 hours

9/11/2017. Hit the road Jack! A review of ADPs (Accelerated Diagnostic Protocols) 2017 COI Disclosures: W. Frank Peacock, MD, FACEP,FACC.

9/11/2017. Hit the road Jack! A review of ADPs (Accelerated Diagnostic Protocols) 2017 COI Disclosures: W. Frank Peacock, MD, FACEP,FACC. Hit the road Jack! A review of ADPs (Accelerated Diagnostic Protocols) 30 minutes W. FRANK PEACOCK, MD, FACEP, FACC 2017 COI Disclosures: W. Frank Peacock, MD, FACEP,FACC Research Grants: Abbott, Janssen,

More information

High-Sensitivity Cardiac Troponin in Suspected ACS

High-Sensitivity Cardiac Troponin in Suspected ACS 15 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes STATE-OF-THE-ART High-Sensitivity Cardiac Troponin in Suspected ACS David A. Morrow, MD, MPH Director, Levine Cardiac Intensive Care

More information

Dolore Toracico e Livelli di Troponina non Misurabili

Dolore Toracico e Livelli di Troponina non Misurabili Dolore Toracico e Livelli di Troponina non Misurabili Andrea Fabbri Dipartimento di Emergenza Presidio Ospedaliero Morgagni Pierantoni Azienda USL Romagna Forlì andrea.fabbri@auslromagna.it Rapid Exclusion

More information

High Sensitivity Troponin Improves Management. But Not Yet

High Sensitivity Troponin Improves Management. But Not Yet High Sensitivity Troponin Improves Management But Not Yet Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory Medicine

More information

Mario Plebani University-Hospital of Padova, Italy

Mario Plebani University-Hospital of Padova, Italy Mario Plebani University-Hospital of Padova, Italy CK-MB mass assay CHF guidelines use BNP for rule out AST in AMI CK in AMI INH for CK-MB electrophoresis for CK and LD isoenzymes RIA for myoglobin WHO

More information

Rapid Disposition of Chest Pain Patients February 2019

Rapid Disposition of Chest Pain Patients February 2019 UCSF High Risk Emergency Medicine Rapid Disposition of Chest Pain Patients February 2019 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International

More information

BioRemarkable Symposium

BioRemarkable Symposium BACC BioRemarkable Symposium Acute Myocardial infarction Stefan Blankenberg University Heart Center Hamburg London, September 7th, 2017 Universitätsklinikum Hamburg-Eppendorf Third Universal-Definition

More information

Troponin when is an assay high sensitive?

Troponin when is an assay high sensitive? Troponin when is an assay high sensitive? Professor P. O. Collinson MA MB BChir FRCPath FRCP edin MD FACB EurClin Chem Consultant Chemical Pathologist and Professor of Cardiovascular Biomarkers, Departments

More information

. θωρακικούάλγουςστα εξωτερικά ιατρεία

. θωρακικούάλγουςστα εξωτερικά ιατρεία . θωρακικούάλγουςστα εξωτερικά ιατρεία Ε.Γ. ΑΛΑΜΑΓΚΑ ΚΑΡ ΙΟΛΟΓΟΣ ιδάκτωρ Ιατρικής Σχολής ΑΠΘ ΓΕΝΙΚΗ ΚΛΙΝΙΚΗ ΘΕΣΣΑΛΟΝΙΚΗΣ ΕΠΙΣΤΗΜΟΝΙΚΟΣ ΣΥΝΕΡΓΑΤΗΣ Α ΚΑΡ ΙΟΛΟΓΙΚΗΣ ΚΛΙΝΙΚΗΣ ΝΟΣΟΚΟΜΕΙΟ ΑΧΕΠΑ Panic attack

More information

Congreso Nacional del Laboratorio Clínico 2016

Congreso Nacional del Laboratorio Clínico 2016 Can biomarkers help us make a better use of cardiac imaging for myocardial ischaemia rule-out in the Emergency Department? Alessandro Sionis Director Acute and Intensive Cardiac Care Unit Hospital de la

More information

Troponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives

Troponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives Objectives Low Risk Chest Pain Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine Improve speed and accuracy in assessing patients with possible ACS! Avoid pitfalls

More information

Defining rise and fall of cardiac troponin values

Defining rise and fall of cardiac troponin values Defining rise and fall of cardiac troponin values Doable but Not Simple Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory

More information

Bertil Lindahl Akademiska sjukhuset Uppsala

Bertil Lindahl Akademiska sjukhuset Uppsala Bertil Lindahl Akademiska sjukhuset Uppsala Kriterier för akut hjärtinfarkt Bevis på myokardskada/nekros: Konstaterad höjning och/eller sänkning av biomarkörer (företrädesvis troponin) med minst ett värde

More information

How will new high sensitive troponins affect the criteria?

How will new high sensitive troponins affect the criteria? How will new high sensitive troponins affect the criteria? Hugo A Katus MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Even more sensitive: The new

More information

Use of Biomarkers for Detection of Acute Myocardial Infarction

Use of Biomarkers for Detection of Acute Myocardial Infarction Use of Biomarkers for Detection of Acute Myocardial Infarction Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory Medicine

More information

10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better

10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better 10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department

More information

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

Peri-operative Troponin Measurements - Pathophysiology and Prognosis Peri-operative Troponin Measurements - Pathophysiology and Prognosis Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory

More information

Troponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg

Troponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg Biomarkers for Optimal Management of Heart Failure Troponin Assessment Does it Carry Clinical Message? Stefan Blankenberg University Heart Center Hamburg Congress of the European Society of Cardiology

More information

Low Risk Chest Pain. Objectives. Disclosure. Case 1. Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine

Low Risk Chest Pain. Objectives. Disclosure. Case 1. Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine Disclosure Low Risk Chest Pain No Financial Relationships to Disclose No significant investments or savings Unlimited Expenses Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School

More information

Waiting for High-Sensitivity POCT Cardiac Troponin Assays: Clinical and Analytical Needs I Have a Pain in My Chest That Hurts Very Bad

Waiting for High-Sensitivity POCT Cardiac Troponin Assays: Clinical and Analytical Needs I Have a Pain in My Chest That Hurts Very Bad Waiting for High-Sensitivity POCT Cardiac Troponin Assays: Clinical and Analytical Needs I Have a Pain in My Chest That Hurts Very Bad Fred Apple PhD Hennepin County Medical Center University of Minnesota

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Learning Objectives Learn to recognize the high risk patient Discuss effective management of a high risk NSTEMI patient Review CCS

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr.

High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr. High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr. Marcel El Achkar Chairperson of Laboratory department Nini Hospital Lecturer

More information

Better, higher, lower, faster: increasingly rapid clinical decision making using high-sensitivity cardiac troponin assays

Better, higher, lower, faster: increasingly rapid clinical decision making using high-sensitivity cardiac troponin assays Editorial Page 1 of 5 Better, higher, lower, faster: increasingly rapid clinical decision making using high-sensitivity cardiac troponin assays Noreen van der Linden, Alexander S. Streng, Will K. W. H.

More information

Impact of Troponin Performance on Patient Care

Impact of Troponin Performance on Patient Care Impact of Troponin Performance on Patient Care Linda C, Rogers PhD, DABCC, FACB Agenda Introduction Diagnosis of MI Guidelines Troponin Assay differences Classification of troponin assays Guideline acceptable

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Measuring Natriuretic Peptides in Acute Coronary Syndromes Measuring Natriuretic Peptides in Acute Coronary Syndromes Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Consultant Cardiologist Chief Academic and Scientific Officer St. John Providence Health

More information

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung, MD, PhD; Magnus Johansson, MD, PhD; Martin Holzmann,

More information

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS. Michael W. Cammarata, MD Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

More information

7/31/2018. Overview of Next Generation Cardiac Troponin T High Sensitivity. Disclosures. Course Objectives: high sensitive Troponin T assay

7/31/2018. Overview of Next Generation Cardiac Troponin T High Sensitivity. Disclosures. Course Objectives: high sensitive Troponin T assay Overview of Next Generation Cardiac Troponin T High Sensitivity Arleen Francis Medical & Scientific Liaison Roche Diagnostics 1 Disclosures Arleen Francis is an employee of Roche Diagnostics and a member

More information

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham Chest pain and troponins on the acute take J N Townend Queen Elizabeth Hospital Birmingham 3 rd Universal Definition of Myocardial Infarction Type 1: Spontaneous MI related to atherosclerotic plaque rupture

More information

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR)

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR) Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR) Shaul Atar, MD Department of Cardiology Faculty of Medicine of the Galilee Western Galilee Medical Center, Nahariya, Israel TIMI Risk Score Age 65

More information

CLINICAL GUIDANCE FRAMEWORKS

CLINICAL GUIDANCE FRAMEWORKS IMPROVING CARE PROCESSES FOR PATIENTS WITH POSSIBLE SUSPECTED ACUTE CORONARY SYNDROME (ICARE-ACS): A NATIONAL IMPLEMENTATION TRIAL OF A CLINICAL GUIDANCE FRAMEWORK S Aldous; on behalf of the IcareACS team

More information

Current and Future Imaging Trends in Risk Stratification for CAD

Current and Future Imaging Trends in Risk Stratification for CAD Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction

More information

CARDIOLOGY GRAND ROUNDS

CARDIOLOGY GRAND ROUNDS CARDIOLOGY GRAND ROUNDS Presentation: Speaker: Date: Location: Troponin State of the Art: Past, Present and Future Yader Sandoval, MD Cardiovascular Disease Fellow Minneapolis Heart Institute at Abbott

More information

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part

More information

Fifty shades of Troponin. Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012

Fifty shades of Troponin. Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012 Fifty shades of Troponin Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012 Plaque-fissure and intracoronary thrombus Courtesy Prof. MJ Davies Acute Coronary Syndromes Plaque-fissure and intracoronary

More information

Low concentrations of high-sensitivity troponin T at presentation to the

Low concentrations of high-sensitivity troponin T at presentation to the Title Page Low concentrations of high-sensitivity troponin T at presentation to the Emergency Department. Running head: Early rule-out using high-sensitivity troponin T Article Type: Letter to the Editor

More information

hs-c Tn I high sensitivity troponin I <17 min

hs-c Tn I high sensitivity troponin I <17 min hs-c Tn I high sensitivity troponin I IFCC & ESC compliant 0/ h NSTEMI rule-out / rule-in algorithm POCT whole blood/plasma Results in < 7 minutes

More information

Why and How Should We Switch Clopidogrel to Prasugrel?

Why and How Should We Switch Clopidogrel to Prasugrel? Case Presentation Why and How Should We Switch Clopidogrel to Prasugrel? Shaul Atar Western Galilee Medical Center Nahariya, ISRAEL Case Description A 67 Y. Old Pt. admitted to IM with anginal CP. DM,

More information

Post-Procedural Myocardial Injury or Infarction

Post-Procedural Myocardial Injury or Infarction Post-Procedural Myocardial Injury or Infarction Hugo A Katus MD & Evangelos Giannitsis MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Conflict of Interest:

More information

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia

More information

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN Current Utilities of Cardiac Biomarker Testing at POC June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN 1. Discuss challenges associated with diagnosing Acute Coronary Syndromes (ACS) and Heart Failure

More information

New diagnostic markers for acute coronary syndromes

New diagnostic markers for acute coronary syndromes New diagnostic markers for acute coronary syndromes - Nye diagnostiske markørerer for akutt iskemisk hjertesykdom Bertil Lindahl, Professor Cardiology, Uppsala University and Uppsala Clinical Research

More information

ACCESS hstni SCIENTIFIC LITERATURE

ACCESS hstni SCIENTIFIC LITERATURE ACCESS hstni SCIENTIFIC LITERATURE 2017 2018 Table of contents Performance Evaluation of Access hstni A critical evaluation of the Beckman Coulter Access hstni: Analytical performance, reference interval

More information

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl # Acute Coronary Syndrome - Case Review - Young-Guk Ko, MD Yonsei Cardiovascular Center Yonsei University College of Medicine Case 1 M/39 #4306212 CC D : Severe squeezing chest pain : 4 hours, aggravated

More information

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines

More information

OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT

OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS, IDENTIFICATION, MANAGEMENT OCTOBER 7, 2014 PETE PERAUD, MD SYMPTOMS TYPICAL ATYPICAL IDENTIFICATION EKG CARDIAC BIOMARKERS STEMI VS NON-STEMI VS USA MANAGEMENT

More information

Chest Pain Wave I Webinar. May, 30 th 2017

Chest Pain Wave I Webinar. May, 30 th 2017 Chest Pain Wave I Webinar May, 30 th 2017 Disclaimer The project described is supported by Funding Opportunity Number CMS-1L1-15-002 from the U.S. Department of Health & Human Services, Centers for Medicare

More information

EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME

EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME DEPARTMENT OF CLINICAL SCIENCE AND EDUCATION, SÖDERSJUKHUSET Karolinska Institutet, Stockholm, Sweden EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from

More information

The PAIN Pathway for the Management of Acute Coronary Syndrome

The PAIN Pathway for the Management of Acute Coronary Syndrome 2 The PAIN Pathway for the Management of Acute Coronary Syndrome Eyal Herzog, Emad Aziz, and Mun K. Hong Acute coronary syndrome (ACS) subsumes a spectrum of clinical entities, ranging from unstable angina

More information

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth

More information

Upstream P2Y 12 RB. Stefano Savonitto Divisione di Cardiologia Arcispedale S. Maria Nuova Reggio Emilia

Upstream P2Y 12 RB. Stefano Savonitto Divisione di Cardiologia Arcispedale S. Maria Nuova Reggio Emilia Upstream P2Y 12 RB Stefano Savonitto Divisione di Cardiologia Arcispedale S. Maria Nuova Reggio Emilia Dio può essere dimostrato Le dimostrazioni dell esistenza di Dio IA Dio non può essere dimostrato

More information

The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms. Professor Christian Mueller

The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms. Professor Christian Mueller The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms Professor Christian Mueller Disclosures Swiss National Science Foundation.... Research support / travel support

More information

The clinical performance of the novel POC Minicare ctni-assay. Per Venge, MD PhD Professor in Clinical Chemistry Uppsala University Uppsala, Sweden

The clinical performance of the novel POC Minicare ctni-assay. Per Venge, MD PhD Professor in Clinical Chemistry Uppsala University Uppsala, Sweden The clinical performance of the novel POC Minicare ctni-assay Per Venge, MD PhD Professor in Clinical Chemistry Uppsala University Uppsala, Sweden Disclosure: Per Venge has received consultancy honoraria

More information

Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary

Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary Dániel Aradi MD PhD Interventional Cardiologist Assistant professor

More information

International Journal of Cardiology and Cardiovascular Research Vol. 4(2), pp , September, ISSN:

International Journal of Cardiology and Cardiovascular Research Vol. 4(2), pp , September, ISSN: International Journal of Cardiology and Cardiovascular Research Vol. 4(2), pp. 072-078, September, 2018. www.premierpublishers.org, ISSN: 3102-9869 IJCCR Research Article Copeptin as a Novel Biomarker

More information

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung, MD, PhD; Magnus Johansson, MD, PhD; Martin Holzmann,

More information

Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray

Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning Objectives Describe the acute

More information

When Telemedicine meet Acute Chest Pain Patients How we use in-hospital tele-ecg to improved quality of care and improved D2BT of STEMI patients

When Telemedicine meet Acute Chest Pain Patients How we use in-hospital tele-ecg to improved quality of care and improved D2BT of STEMI patients 2015 Aug 17 11:00-11:45 conference hall: Canterbury When Telemedicine meet Acute Chest Pain Patients How we use in-hospital tele-ecg to improved quality of care and improved D2BT of STEMI patients Chen

More information

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

CHEST PAIN CDU INCLUSION CRITERIA

CHEST PAIN CDU INCLUSION CRITERIA CHEST PAIN CDU INCLUSION CRITERIA No clinical criteria for ACS Stable vital signs Initial ECG and cardiac biomarkers not consistent with ACS Low to intermediate ACS risk (HEART score 0-6) [Ref 1, 2] Plan

More information

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and

More information

Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center

Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center Hospitalizations in the U.S. Due to ACS Acute Coronary Syndromes

More information

The Clinical Value of Cardiac Biomarkers in the Management of Acute Coronary Syndrome And Heart Failure

The Clinical Value of Cardiac Biomarkers in the Management of Acute Coronary Syndrome And Heart Failure Monet N. Sayegh, MD Physician Consultant The Clinical Value of Cardiac Biomarkers in the Management of Acute Coronary Syndrome And Heart Failure Unrestricted Siemens Medical Solutions USA, Inc., 2016 Incidence

More information

Topic. Updates on Definition of Myocardial Infarction

Topic. Updates on Definition of Myocardial Infarction Topic Updates on Definition of Myocardial Infarction In the past, general consensus for MI? Definition of MI by WHO - Combination of 2 of 3 characteristics - 1. Typical Symptoms 2. Enzyme Rise 3. Typical

More information

TOPICS IN EMERGENCY MEDICINE SEMI-FINAL

TOPICS IN EMERGENCY MEDICINE SEMI-FINAL RISK ASSESSMENT IN PATIENTS WITH CHEST PAIN Nora Goldschlager, M.D. FACP, FACC, FAHA, FHRS Cardiology - San Francisco General Hospital UCSF Disclosures: None 1 CHEST PAIN NOT DUE TO MYOCARDIAL ISCHEMIA

More information

Does serial troponin measurement help identify acute ischemia/ischemic events?

Does serial troponin measurement help identify acute ischemia/ischemic events? Does serial troponin measurement help identify acute ischemia/ischemic events? Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine and Laboratory Medicine & Pathology

More information

Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor

Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor Leonardo Bolognese Cardiovascular Department, Arezzo, Italy Platelet Reactivity in Patients with STEMI Undergoing Primary PCI Campo G et

More information

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Chest Pain. Dr Robert Huggett Consultant Cardiologist Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the

More information

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio 1 STABLE ISCHEMIC HEART DISEASE: A NON-INVASIVE CARDIOLOGIST S PERSECTIVE 2018 Cardiovascular Course for Trainees and Early Career Physicians APRIL 20, 2018 David A. Orsinelli, MD, FACC, FASE Professor,

More information

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Improving STEMI outcomes in Denmark Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Presenter Disclosure Information Study funded by Fondation Leducq Michael Rahbek Schmidt The

More information

Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting. Krysten Pilkington MNSc, APRN, AG-ACNP-BC

Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting. Krysten Pilkington MNSc, APRN, AG-ACNP-BC Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting Krysten Pilkington MNSc, APRN, AG-ACNP-BC Where do we start? Onset Location Duration Characteristics Aggravating & Alleviating factors

More information

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? Salim S. Virani, MD, PhD, FACC, FAHA Associate Professor, Section of Cardiovascular Research Baylor

More information

The Clinical Laboratory Working with Physicians to Improve Patient Care

The Clinical Laboratory Working with Physicians to Improve Patient Care The Clinical Laboratory Working with Physicians to Improve Patient Care Michael A. Pesce, PhD Professor Emeritus Columbia University Medical Center Department of Pathology and Cell Biology Objectives Troponin

More information

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,

More information

Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine

Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine Research funding: American Heart Association Donaghue Foundation/ Association of American

More information

Biomarkers Now and in the Future of Emergency Medicine- TIME TO USE sst2 Alan S. Maisel MD FACC Professor of Medicine, Emeritus University of

Biomarkers Now and in the Future of Emergency Medicine- TIME TO USE sst2 Alan S. Maisel MD FACC Professor of Medicine, Emeritus University of Biomarkers Now and in the Future of Emergency Medicine- TIME TO USE sst2 Alan S. Maisel MD FACC Professor of Medicine, Emeritus University of California, San Diego, Chest Pain, Shortness of breath: We

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2 Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial

More information

Using DOACs in CAD Patients in Sinus Ryhthm Results of the ATLAS ACS 2, COMPASS and COMMANDER-HF Trials

Using DOACs in CAD Patients in Sinus Ryhthm Results of the ATLAS ACS 2, COMPASS and COMMANDER-HF Trials Using DOACs in CAD Patients in Sinus Ryhthm Results of the ATLAS ACS 2, COMPASS and COMMANDER-HF Trials 19 th Annual San Diego Heart Failure Symposium for Primary Care Physicians January 11-12, 2019 La

More information

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients

More information

Rapid rule out of acute myocardial infarction: novel biomarker-based strategies

Rapid rule out of acute myocardial infarction: novel biomarker-based strategies 653229ACC0010.1177/2048872616653229European Heart Journal: Acute Cardiovascular CareMueller et al. research-article2016 Original scientific paper Rapid rule out of acute myocardial infarction: novel biomarker-based

More information

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of

More information

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained? TROPONIN POSITIVE WHAT DOES IT MEAN? Frequently Asked Questions Regarding the Use of Troponin in the Clinical Setting What does an elevated troponin level mean? Elevated troponin is a sensitive and specific

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

More information

Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD

Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD Disclosures Research contracts: AstraZeneca, Bayer, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, The Medicines Company,

More information

Recent community campaigns on

Recent community campaigns on Availability of highly sensitive troponin assays and acute coronary syndrome care: insights from the SNAPSHOT registry Use of hs troponin testing of patients hospitalised with possible ACS was associated

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D. The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum David C. Levin, M.D. October 16, 2016 MPI Utilization Rates/1000[includes PET] total radiologists 2014 total

More information

Adults With Diagnosed Diabetes

Adults With Diagnosed Diabetes Adults With Diagnosed Diabetes 1990 No data available Less than 4% 4%-6% Above 6% Mokdad AH, et al. Diabetes Care. 2000;23(9):1278-1283. Adults With Diagnosed Diabetes 2000 4%-6% Above 6% Mokdad AH, et

More information

Hospital-Acquired Anemia: Epidemiology, Prevention and Management in Patients with Acute Coronary Syndromes

Hospital-Acquired Anemia: Epidemiology, Prevention and Management in Patients with Acute Coronary Syndromes Hospital-Acquired Anemia: Epidemiology, Prevention and Management in Patients with Acute Coronary Syndromes Adam C. Salisbury, MD, MSc January 23, 2012 Case 64 year old woman with no cardiac history, medical

More information

Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain

Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain Elevation of cardiac troponin (ctn) levels is central to the definition of acute myocardial infarction (AMI). 1 Increasingly sensitive ctn assays offer the potential for AMI to be diagnosed earlier than

More information

DIAGNOSTICS ASSESSMENT PROGRAMME

DIAGNOSTICS ASSESSMENT PROGRAMME DIAGNOSTICS ASSESSMENT PROGRAMME Evidence overview Early rule out or diagnosis of acute myocardial infarction: High-sensitivity troponin tests (Elecsys troponin T high-sensitive, ARCHITECT STAT highsensitivity

More information